NanoVibronix Inc. has announced a new Securities Purchase Agreement with an institutional investor, dated July 18, 2025. As part of this agreement, NanoVibronix will sell 8,889 shares of its newly-designated Series H Convertible Preferred Stock, valued at $1,000 per share, and warrants for up to 4,678,363 shares of common stock. This transaction, which closed on July 22, 2025, raised $8 million in gross proceeds. The company plans to use $5 million to redeem Series X Preferred Stock and allocate the remainder for working capital. The agreement requires stockholder approval for issuing shares beyond 19.99% of current common stock at prices below Nasdaq's minimum price rules.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。